| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9257577 | Critical Reviews in Oncology/Hematology | 2005 | 14 Pages |
Abstract
Refining the molecular monitoring of MRD by quantitative RT-PCR, better elucidation of the biologic mechanisms, and the identification of prognostic factors might be helpful to make further progress in the treatment of APL.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Eva Lengfelder, Susanne Saussele, Andreas Weisser, Thomas Büchner, Rüdiger Hehlmann,